ResMed Inc. (LON:0KW4)

Market Cap	27.98B -1.7%
Revenue (ttm)	4.01B +9.6%
Net Income	1.10B +19.0%
EPS	7.51 +19.4%
Shares Out	n/a
PE Ratio	25.34
Forward PE	22.29
Dividend	1.74 (0.68%)
Ex-Dividend Date	Feb 12, 2026

Volume	15
Average Volume	289
Open	262.45
Previous Close	256.58
Day's Range	255.00 - 262.45
52-Week Range	199.71 - 297.98
Beta	0.88
RSI	50.36
Earnings Date	Jan 29, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KW4

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD